Robin Carhart-Harris, PhD, is an esteemed neuropharmacologist, psychologist, and became the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco in 2021.With a PhD in psychopharmacology from the University of Bristol, Dr. Carhart-Harris and his colleagues have completed multimodal human functional neuroimaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for various disorders. His current research program at UCSF is focused on the mechanisms of action of psychedelics and psychedelic-therapy. Dr. Carhart-Harris has published in The New England Journal of Medicine, Nature, Nature Medicine, Cell, Lancet Psychiatry, and more. He spoke was named among the top 31 medical scientists by The Times newspaper in 2020, listed in TIME magazine’s “100 Next” in 2021, voted psychedelic researcher of the year in 2021, and listed in Vox Magazine’s “Future 50” in 2023. His website is carhartharrislab.com.